These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12162700)

  • 1. Discovery and development of respirable antisense therapeutics for asthma.
    Sandrasagra A; Leonard SA; Tang L; Teng K; Li Y; Ball HA; Mannion JC; Nyce JW
    Antisense Nucleic Acid Drug Dev; 2002 Jun; 12(3):177-81. PubMed ID: 12162700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RASONs: a novel antisense oligonucleotide therapeutic approach for asthma.
    Sandrasagra A; Tang L; Leonard SA; Teng K; Li Y; Mannion JC; Nyce JW
    Expert Opin Biol Ther; 2001 Nov; 1(6):979-83. PubMed ID: 11728229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respirable antisense oligonucleotides: a new drug class for respiratory disease.
    Tanaka M; Nyce JW
    Respir Res; 2001; 2(1):5-9. PubMed ID: 11686859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical potential of respirable antisense oligonucleotides (RASONs) in asthma.
    Ball HA; Sandrasagra A; Tang L; Van Scott M; Wild J; Nyce JW
    Am J Pharmacogenomics; 2003; 3(2):97-106. PubMed ID: 12749727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption, distribution, metabolism, and excretion of a respirable antisense oligonucleotide for asthma.
    Ali S; Leonard SA; Kukoly CA; Metzger WJ; Wooles WR; McGinty JF; Tanaka M; Sandrasagra A; Nyce JW
    Am J Respir Crit Care Med; 2001 Mar; 163(4):989-93. PubMed ID: 11282778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respirable antisense oligonucleotides: a new, third drug class targeting respiratory disease.
    Nyce J
    Curr Opin Allergy Clin Immunol; 2002 Dec; 2(6):533-6. PubMed ID: 14752337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technology evaluation: EPI-2010, EpiGenesis.
    Zhang Z
    Curr Opin Mol Ther; 2002 Jun; 4(3):275-80. PubMed ID: 12139314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respirable antisense oligonucleotide (RASON) therapy for allergic asthma.
    Metzger WJ; Nyce JW
    BioDrugs; 1999 Oct; 12(4):237-43. PubMed ID: 18031178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sense and antisense: therapeutic potential of oligonucleotides and interference RNA in asthma and allergic disorders.
    Ball HA; Van Scott MR; Robinson CB
    Clin Rev Allergy Immunol; 2004 Dec; 27(3):207-17. PubMed ID: 15630157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advantageous toxicity profile of inhaled antisense oligonucleotides following chronic dosing in non-human primates.
    Guimond A; Viau E; Aubé P; Renzi PM; Paquet L; Ferrari N
    Pulm Pharmacol Ther; 2008 Dec; 21(6):845-54. PubMed ID: 18761414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respirable antisense oligonucleotides as novel therapeutic agents for asthma and other pulmonary diseases.
    Nyce JW
    Expert Opin Investig Drugs; 1997 Sep; 6(9):1149-56. PubMed ID: 15991889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic applications of antisense oligonucleotides in asthma and allergy.
    Isidoro-García M; Dávila I
    Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):171-5. PubMed ID: 19075979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The disposition (ADME) of antisense oligonucleotides.
    Dvorchik BH
    Curr Opin Mol Ther; 2000 Jun; 2(3):253-7. PubMed ID: 11249618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense oligonucleotide-based therapeutics for cancer.
    Dean NM; Bennett CF
    Oncogene; 2003 Dec; 22(56):9087-96. PubMed ID: 14663487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency of antisense oligonucleotide drug discovery.
    Bennett CF
    Antisense Nucleic Acid Drug Dev; 2002 Jun; 12(3):215-24. PubMed ID: 12162703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming biological barriers to in vivo efficacy of antisense oligonucleotides.
    White PJ; Anastasopoulos F; Pouton CW; Boyd BJ
    Expert Rev Mol Med; 2009 Mar; 11():e10. PubMed ID: 19302730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense oligonucleotides on neurobehavior, respiratory, and cardiovascular function, and hERG channel current studies.
    Kim TW; Kim KS; Seo JW; Park SY; Henry SP
    J Pharmacol Toxicol Methods; 2014; 69(1):49-60. PubMed ID: 24211663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense oligonucleotides as therapeutics for malignant diseases.
    Ho PT; Parkinson DR
    Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled p38alpha mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice.
    Duan W; Chan JH; McKay K; Crosby JR; Choo HH; Leung BP; Karras JG; Wong WS
    Am J Respir Crit Care Med; 2005 Mar; 171(6):571-8. PubMed ID: 15557129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.